Tasquinimod

Tasquinimod is a quinoline-3-carboxamide linomide analogue with antiangiogenic and potential antineoplastic activities. Tasquinimod has been shown to decrease blood vessel density but the exact mechanism of action is not known. This agent has also been shown to augment the antineoplastic effects of docetaxel and androgen ablation in a murine model of prostate cancer involving human prostate cancer xenografts. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include tasquinimodum, (N-Methyl-N-(4-trifluoromethyl-phenyl)-1 and 2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide). Its PubChem CID is 54682876.

CAS No 254964-60-8
Molecular Formula C20H17F3N2O4
Molecular Weight 406.4 g/mol
Synonyms 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide

Frequently Asked Questions